Articles From: easyhome Appoints New Director to FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab


2014/11/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978136001&sourceType=1 http://www.ccnmatthews.com/logos2/eh1103.gif MISSISSAUGA, ONTARIO --
Sign-up for easyhome Appoints New Director investment picks
BOCA RATON, Fla., Nov.
Sign-up for eCareer Relaunches Openreq With Revolutionary Job Matching Technology investment picks
2014/11/10
Quarterly Revenue Reaches Approximately $7.3 Million; Net Loss Reduced by 26% to Approximately $2.4 Million Adjusted EBITDA Increases to Over $1.0 Million Company to Host Quarterly Earnings Conference Call on November 18, 2014 OKLAHOMA CITY , Nov.
Sign-up for Elephant Talk Announces Preliminary Third Quarter Financial Results investment picks
OLD GREENWICH, Conn.
Sign-up for Ellington Residential Mortgage REIT Reports Third Quarter 2014 Results investment picks
2014/11/10
A new University of Phoenix national military survey suggests that while the veteran unemployment rate continues to decline i , many veterans may actually be underemployed.
Sign-up for Employment Outlook for Service Members Continues to Improve, But Translating Skills to Civilian Jobs Still a Challenge for Many Veterans, Reveals University of Phoenix Survey investment picks
DUBLIN , Nov.
Sign-up for Endo Receives Final Approval for Generic Version of Valcyte® investment picks
THIRD QUARTER SUMMARY: Total revenue increased 10% to $5.3 million in the third quarter of 2014, from $4.9 million in the third quarter of 2013 Gross profit margin was 44% in the current period, compared to 60% in the third quarter of 2013, as a result of a product mix shift and lower production levels Operating expenses increased $1.0 million, or 15%, from $6.8 million in the third quarter of 2013 to $7.8 million in the current period due to increased sales & marketing and research & development expenses Net loss of $(5.5) million, or $(0.11) per share, in the third quarter of 2014, compared to $(3.9) million, or $(0.08) per share, in the third quarter of 2013, on decreased gross profit margin and higher operating expenses SAN LEANDRO, Calif., Nov.
Sign-up for Energy Recovery Reports Unaudited Financial Results for the Third Quarter Of 2014 investment picks
HAMILTON, Bermuda, Nov.
Sign-up for Enstar Group Limited Reports Third Quarter Results investment picks
SAN DIEGO, Nov.
Sign-up for Entropic Announces CEO Transition investment picks
2014/11/10
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS ), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today provided a corporate update and reported financial results for the third quarter ended September 30, 2014.
Sign-up for EPIRUS Biopharmaceuticals Reports Third Quarter Results and Provides Corporate Update investment picks
EPR Properties (NYSE: EPR) today announced that the Company’s President and CEO, David Brain, appeared as a featured guest on CNBC’s “Mad Money with Jim Cramer” Friday, November 7, 2014.
Sign-up for EPR Properties CEO David Brain Appears on CNBC’s “Mad Money with Jim Cramer” investment picks
The Rosen Law Firm announces that it is investigating potential securities claims against Rayonier, Inc. (NYSE:RYN) on behalf of its shareholders resulting from allegations that the company may have issued materially misleading business information to the investing public.
Sign-up for EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Rayonier, Inc. investment picks
2014/11/10
Survey finds that consumers of all generations value smart technology features in both current and future homes MADISON, N.J. , Nov.
Sign-up for ERA Real Estate and HGTV Identify Top Trends in Smart Home Technology investment picks
Eros International Plc (NYSE:EROS) (“Eros”), a leading global company in the Indian film entertainment industry, announced today that it has acquired the worldwide exploitation rights of the Tamil film Lingaa , starring Rajinikanth and directed by K.S. Ravikumar.
Sign-up for Eros International Acquires Worldwide Rights of Rajinikanth’s Lingaa investment picks
Backup Technology (BTL), which specialises in online backup & disaster recovery services for global enterprises, is helping Essex County Fire & Rescue Service (ECFRS) safeguard the data it generates as it protects local people and property.
Sign-up for Essex County Fire & Rescue Service Protects Data with Backup Technology investment picks
http://media.marketwire.com/attachments/201305/158976_EuroseasLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157667&ProfileId=051205&sourceType=1 MAROUSSI, ATHENS, GREECE --
Sign-up for Euroseas Ltd. Reports Results for the Nine-Month Period and Quarter Ended September 30, 2014 investment picks
LANCASTER, Ohio, Nov.
Sign-up for EveryWare Global to Host Third Quarter 2014 Earnings Conference Call investment picks
REHOVOT, Israel, Nov.
Sign-up for Evogene Reports Third Quarter 2014 Financial Results investment picks
2014/11/10
Ford Motor Company is collaborating with Wind Energy Corporation to bring a new and innovative source of clean energy to its dealers.
Sign-up for Exclusive Pilot Program with Wind Energy Corporation Brings Clean Energy to Select Ford Dealers investment picks
Exelis ( NYSE: XLS ) has signed a teaming agreement with Airbus Group to provide advanced missile warning capabilities for U.S. and international F-16 Fighting Falcon aircraft.
Sign-up for Exelis, Airbus partner to provide missile warning capabilities for US and international F-16 aircraft investment picks
2014/11/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978153001&sourceType=1 http://media3.marketwire.com/logos/20120517-bbd-eng-big.jpg TORONTO, ONTARIO --
Sign-up for Falcon Aviation Services Places Firm Order for Three Bombardier Q400 NextGen Turboprop Aircraft investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: easyhome Appoints New Director to FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent